Skip to content

A randomized controlled trial evaluating the effect of physical rehabilitation therapy on the recovery of upper limb motor function in patients with axillary plexus syndrome after breast cancer surgery

A randomized controlled trial evaluating the effect of physical rehabilitation therapy on the recovery of upper limb motor function in patients with axillary plexus syndrome after breast cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121204
Enrollment
Unknown
Registered
2026-03-26
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillary web syndrome

Interventions

Control group:Watch regular rehabilitation videos and perform regular rehabilitation exercises.
Specialized Physical Intervention Group:Rehabilitation education, sliding pulley rings, shoulder climbing ladder, manual soft tissue release surgery (on the 3rd day after surgery and on the 3rd week a

Sponsors

Zhujiang Hospital, Southern Medical University,Guangzhou,510280,China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female, aged 18 years or above; 2. Patients who have undergone histological pathological examination and have been diagnosed with breast cancer according to the pathological classification of the WHO Breast Tumor Classification; 3. Patients who underwent unilateral radical mastectomy combined with sentinel lymph node biopsy or axillary lymph node dissection (open, laparoscopic or robot-assisted), and developed axillary web syndrome after the surgery. The diagnostic criteria for axillary web syndrome: Through clinical physical examination or ultrasound, it is determined that there are cord-like nodules in the axilla, the inner side of the arm, the forearm or the wrist of the patient, and at the same time, there is limited movement of the affected side shoulder joint, decreased muscle strength, subcutaneous emphysema, pain (VAS score >= 2 points), or lymphedema of the upper limb on the affected side (stage 0-I); 4. The subjects voluntarily cooperated with this study and signed the informed consent form; 5. ECOG score 0-1 point.

Exclusion criteria

Exclusion criteria: 1. Shoulder joint range of motion limitation caused by orthopedic, rheumatoid immune, or trauma-related reasons, and it is expected that the patient cannot complete the rehabilitation actions set by the study; 2. Postoperative complications in other systems, such as pneumonia, deep vein thrombosis of the lower extremities; 3. Patients with cardiac insufficiency: New York Heart Association cardiac function classification >= III grade; or left ventricular ejection fraction 15 hours); 5. Patients with renal insufficiency: Glomerular filtration rate < 30 mL/min/1.73m^2, or undergoing maintenance dialysis treatment; 6. Patients with liver insufficiency: Child-Pugh classification B or C; 7. Severe hematological diseases: Hemoglobin < 70 g/L, platelet count < 50 × 10^9/L, neutrophil count < 0.5 × 10^9/L; 8. Other serious systemic diseases that may affect the safety and efficacy evaluation of rehabilitation; 9. Unable to cooperate with physical rehabilitation treatment or follow-up; 10. Having contraindications for hyperbaric oxygen therapy; 11. Pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
The improvement values of shoulder joint flexion range of motion 12 weeks after the intervention, the improvement values of shoulder joint abduction range of motion;

Secondary

MeasureTime frame
The improvement values of shoulder flexion range of motion and shoulder abduction range of motion at 3 weeks after intervention;The improvement degree of muscle strength grading at 3 weeks and 12 weeks after intervention;The VAS score for pain 1 day after intervention.;The FACTB assessment scale score after 12 weeks of intervention;The extent of subcutaneous emphysema and the time for its absorption one day after the intervention;The degree of lymphedema improvement one day after the intervention;

Countries

China

Contacts

Public ContactMei Yang

Zhujiang Hospital, Southern Medical University,Guangzhou,510280,China

yangmei286@163.com+86 137 2542 1149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026